ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

NRC considering “Escalated” Enforcement Action Against NIH

February 2, 1996

Peters Leaves NCI For CF Foundation

February 3, 1978

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee

June 14, 2013

Changes In Cooperative Groups As Result Of Move To DCT Topic Of Chairmen’s Meeting Sept. 16

August 22, 1975

Includes May issue of Business & Regulatory Report.

May 31, 2002